HighVista Strategies’s Thermo Fisher Scientific TMO Stock Holding History

HighVista Strategies’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,269	Closed	-$1.31M	–	176
2025 Q4	$1.31M	Buy	+2,269	New	+$1.28M	0.34%	79
2024 Q2	–	Sell	-1,900	Closed	-$1.1M	–	159
2024 Q1	$1.1M	Buy	+1,900	New	+$1.07M	0.39%	87
2016 Q2	–	Sell	-23,997	Closed	-$3.4M	–	204
2016 Q1	$3.4M	Buy	+23,997	New	+$3.22M	0.64%	47
2014 Q2	–	Sell	-40,359	Closed	-$4.67M	–	170
2014 Q1	$4.67M	Buy	40,359 +32,709	+428%	+$3.89M	0.62%	60
2013 Q4	$852K	Buy	+7,650	New	+$761K	0.15%	78

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HighVista Strategies's TMO Position: Q1 2026 in Review

HighVista Strategies sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 2,269 shares — an estimated $1.31M sold.

HighVista Strategies first reported a position in TMO in Q4 2013 and held it in 5 quarters. The position peaked at $4.67M in Q1 2014. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

HighVista Strategies reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
HighVista Strategies sold 2,269 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.31M.
HighVista Strategies first reported a position in Thermo Fisher Scientific in Q4 2013 and held it in 5 quarters.
HighVista Strategies's Thermo Fisher Scientific position peaked at $4.67M in Q1 2014.
2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on HighVista Strategies's 13F filing for Q1 2026, filed 15 May 2026.